Saadi Ryan H. bought TVGN

February 14, 2024 · Form 4 insider transaction

Saadi Ryan H. bought 98,901,098 shares of Tevogen Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
98,901,098
Price
N/A
Total value
N/A
Role
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2024
Filing dateFebruary 16, 2024
Shares owned after98,901,098
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On February 14, 2024 (the "Effective Date"), pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc ("Tevogen"), each issued and outstanding share of common stock of Tevogen ("Tevogen common stock") was automatically cancelled and converted into approximately 4.8481 (the "Exchange Ratio") shares of the common stock of the Issuer.

View the original Form 4 on SEC EDGAR